29 November 2016

KCR on Oversight and Governance at PCT Europe 2016

Mike Jagielski, President and CEO of KCR, during the panel ‘How to be more effective with oversight and governance – roles and responsibility’

Berlin – 29 November 2016 – Complex clinical projects demand effective governance. How to be more effective with oversight and governance was one of the themes examined during the latest Partnerships in Clinical Trials (PCT) Europe conference, which took place in Vienna from 15 - 17 November 2016. Mike Jagielski, President and CEO of KCR, was the only delegate representing a contract research organization (CRO) during the panel discussing roles and responsibilities as well as other cooperation issues for clinical trials conduct with executives from Teva, AbbVie, Bayer and Abbot Laboratories.

“PCT 2016 was a powerful platform for exchanging opinions and ideas within the industry. The panel on oversight and governance triggered an interesting discussion among sponsors and CROs regarding effective collaboration,” said Mike Jagielski. “We all agreed that sharing roles and responsibilities requires transparent relations in order to make the trial successful."

Main thoughts from the panel ‘How to be more effective with oversight and governance – roles and responsibility’ include:

- There is no single oversight model applying to all studies 

- Every project demands oversight model negotiations to balance responsibility and synchronize terminology

- The importance of direct and fast feedback is not easy to establish from a CRO perspective as the business relationship is also in play - moving beyond that quickly is key

- The skill level of CRO and Sponsor dictates the best and most effective oversight model - always assuming oversight is required and should not have a negative association.

“Thanks to an open and honest conversation among all parties involved, we are all able to clearly express our positions and reach mutual understanding regarding project requirements,” summarized Mr. Jagielski.

Another year to continue its Marketing with Meaning campaign - KCR supports German Children Cancer Foundation

PCT Europe 2016 was also another outstanding occasion for KCR to continue its Marketing with Meaning campaign. Third year in a row the company used its promotional action at the conference to support children’s charity. More than 300 copies of the company newspaper called KCR Times were distributed during the event in Vienna. Each distributed copy prompted a KCR donation of 3 EUR to the German Children Cancer Foundation. We would like to thank all PCT 2016 participants for taking part in this charity project.

About KCR
KCR is a Contract Research Organization (CRO) providing strategic clinical development solutions for the pharmaceutical, biotechnology and medical device industries in Europe, Israel and the U.S. More than 300 professionals support clients with full-service capabilities across our three main service areas: Trial Execution (TE), Functional Service Provision (FS) and Late Phase (LP). Focusing on knowledge, quality and innovation, KCR delivers high value solutions customized to clients' needs. Headquartered in Berlin, Germany, KCR operates across 19 countries in Europe as well as the U.S. For more information, visit www.kcrcro.com.

KCR: We see human behind every number.

Media Contact

Joanna Lewandowska
Associate Director, PR & Marketing
mobile: (+48) 605 053 164